Complete financial analysis of Yuki Gosei Kogyo Co., Ltd. (4531.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yuki Gosei Kogyo Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- Buffettique Growth ETP (BUFE.L) Income Statement Analysis – Financial Results
- Elevai Labs, Inc. Common Stock (ELAB) Income Statement Analysis – Financial Results
- Nerdy, Inc. (NRDY-WT) Income Statement Analysis – Financial Results
- Rede D’Or São Luiz S.A. (RDOR3.SA) Income Statement Analysis – Financial Results
- Yifan Pharmaceutical Co., Ltd. (002019.SZ) Income Statement Analysis – Financial Results
Yuki Gosei Kogyo Co., Ltd. (4531.T)
About Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.93B | 12.84B | 12.36B | 11.09B | 10.72B | 10.27B | 10.07B | 10.40B | 10.58B | 10.01B | 9.42B | 8.61B | 8.12B | 9.32B | 9.60B | 10.41B | 10.50B |
| Cost of Revenue | 9.67B | 9.79B | 10.01B | 9.27B | 8.42B | 8.49B | 8.13B | 8.12B | 8.32B | 8.14B | 7.51B | 7.19B | 6.19B | 7.19B | 7.99B | 8.13B | 8.12B |
| Gross Profit | 3.26B | 3.05B | 2.36B | 1.82B | 2.30B | 1.78B | 1.95B | 2.27B | 2.25B | 1.87B | 1.92B | 1.42B | 1.93B | 2.13B | 1.62B | 2.28B | 2.38B |
| Gross Profit Ratio | 25.21% | 23.75% | 19.06% | 16.43% | 21.46% | 17.36% | 19.32% | 21.86% | 21.32% | 18.69% | 20.34% | 16.49% | 23.77% | 22.86% | 16.83% | 21.93% | 22.64% |
| Research & Development | 639.00M | 589.00M | 377.00M | 211.00M | 629.00M | 345.00M | 338.00M | 404.29M | 407.31M | 276.40M | 360.48M | 161.99M | 225.93M | 431.44M | 363.41M | 568.55M | 430.11M |
| General & Administrative | 1.19B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 461.07M | 472.02M | 447.77M | 437.55M | 514.46M | 502.99M | 553.16M | 476.24M | 635.99M | 520.31M |
| Selling & Marketing | 239.00M | 297.00M | 425.00M | 274.00M | 245.00M | 224.00M | 254.00M | 333.62M | 339.34M | 327.51M | 299.51M | 248.85M | 234.90M | 311.66M | 312.72M | 348.53M | 322.22M |
| SG&A | 1.43B | 297.00M | 425.00M | 274.00M | 245.00M | 224.00M | 254.00M | 794.69M | 811.35M | 775.28M | 737.06M | 763.31M | 737.88M | 864.82M | 788.96M | 984.52M | 842.52M |
| Other Expenses | 71.00M | -253.00M | -27.00M | -34.00M | 90.00M | -32.00M | 9.00M | -648.00K | 55.27M | 65.08M | 112.17M | 52.46M | 21.38M | 24.38M | 14.84M | -6.25M | 20.21M |
| Operating Expenses | 2.14B | 2.15B | 1.94B | 1.60B | 1.99B | 1.73B | 1.74B | 1.27B | 1.29B | 1.13B | 1.17B | 1.09B | 1.05B | 1.39B | 1.23B | 1.64B | 1.36B |
| Cost & Expenses | 11.81B | 11.94B | 11.94B | 10.87B | 10.40B | 10.22B | 9.86B | 9.39B | 9.61B | 9.27B | 8.67B | 8.28B | 7.24B | 8.58B | 9.22B | 9.77B | 9.48B |
| Interest Income | 0.00 | 11.00M | 16.00M | 20.00M | 0.00 | 6.00M | 0.00 | 544.00K | 774.00K | 882.00K | 974.00K | 873.00K | 1.01M | 1.06M | 1.63M | 3.88M | 3.99M |
| Interest Expense | 49.00M | 50.00M | 50.00M | 52.00M | 49.00M | 54.00M | 45.00M | 42.71M | 49.11M | 57.91M | 54.30M | 57.73M | 53.97M | 60.97M | 78.61M | 84.16M | 89.28M |
| Depreciation & Amortization | 977.00M | 874.00M | 839.00M | 895.00M | 940.00M | 889.00M | 658.00M | 632.40M | 519.52M | 511.69M | 559.55M | 749.78M | 866.49M | 855.96M | 914.94M | 1.27B | 1.20B |
| EBITDA | 1.88B | 1.57B | 1.18B | 1.27B | 1.25B | 939.00M | 864.00M | 1.08B | 1.02B | 942.32M | 867.16M | 1.46B | 964.05M | 990.01M | 601.87M | 538.95M | 1.73B |
| EBITDA Ratio | 14.57% | 12.76% | 10.86% | 10.73% | 12.98% | 9.39% | 9.21% | 15.72% | 14.57% | 13.29% | 15.08% | 13.14% | 21.75% | 17.29% | 13.73% | 18.16% | 21.32% |
| Operating Income | 1.13B | 897.00M | 413.00M | 218.00M | 312.00M | 49.00M | 205.00M | 454.65M | 458.46M | 232.94M | 231.02M | 7.54M | 487.93M | 307.55M | -151.23M | 176.34M | 443.72M |
| Operating Income Ratio | 8.70% | 6.99% | 3.34% | 1.97% | 2.91% | 0.48% | 2.04% | 4.37% | 4.33% | 2.33% | 2.45% | 0.09% | 6.01% | 3.30% | -1.57% | 1.69% | 4.23% |
| Total Other Income/Expenses | -220.00M | -256.00M | -124.00M | 101.00M | -361.00M | 92.00M | -36.00M | -54.00M | -4.25M | 139.60M | 22.08M | 643.14M | -446.38M | -234.47M | -240.46M | -992.25M | -4.55M |
| Income Before Tax | 905.00M | 641.00M | 289.00M | 319.00M | -49.00M | 141.00M | 169.00M | 400.14M | 454.21M | 372.54M | 253.10M | 650.67M | 41.56M | 73.08M | -391.68M | -815.90M | 439.17M |
| Income Before Tax Ratio | 7.00% | 4.99% | 2.34% | 2.88% | -0.46% | 1.37% | 1.68% | 3.85% | 4.29% | 3.72% | 2.69% | 7.56% | 0.51% | 0.78% | -4.08% | -7.84% | 4.18% |
| Income Tax Expense | 129.00M | 84.00M | 41.00M | 31.00M | -6.00M | 37.00M | 44.00M | 44.83M | 103.46M | 42.33M | 199.60M | 312.78M | -166.18M | 85.05M | 175.94M | -33.03M | 177.53M |
| Net Income | 776.00M | 556.00M | 248.00M | 288.00M | -42.00M | 104.00M | 125.00M | 355.31M | 350.75M | 330.21M | 53.50M | 337.89M | 207.74M | -11.96M | -567.62M | -782.88M | 261.65M |
| Net Income Ratio | 6.00% | 4.33% | 2.01% | 2.60% | -0.39% | 1.01% | 1.24% | 3.42% | 3.32% | 3.30% | 0.57% | 3.92% | 2.56% | -0.13% | -5.91% | -7.52% | 2.49% |
| EPS | 35.56 | 25.48 | 11.36 | 13.20 | -1.92 | 4.76 | 5.73 | 16.28 | 16.07 | 15.12 | 2.45 | 15.47 | 9.51 | -0.55 | -25.97 | -35.79 | 11.95 |
| EPS Diluted | 35.56 | 25.48 | 11.36 | 13.20 | -1.92 | 4.76 | 5.73 | 16.28 | 16.07 | 15.12 | 2.45 | 15.47 | 9.51 | -0.55 | -25.97 | -35.79 | 11.95 |
| Weighted Avg Shares Out | 21.82M | 21.82M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.84M | 21.84M | 21.84M | 21.84M | 21.86M | 21.88M | 21.89M |
| Weighted Avg Shares Out (Dil) | 21.82M | 21.82M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.83M | 21.84M | 21.84M | 21.84M | 21.84M | 21.86M | 21.88M | 21.89M |
Source: https://incomestatements.info
Category: Stock Reports